Schlumberger NV vs Tilray Brands Inc — how do they compare? Schlumberger NV trades at $48.97 (market cap $71.18B), while Tilray Brands Inc trades at $3.64 (market cap $549.01M). The key difference: Schlumberger NV is far larger — about 129.7× Tilray Brands Inc's market cap, and Schlumberger NV pays a 2.46% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Schlumberger NV for 99 Days and Tilray Brands Inc for 31 Days on average.
| SLB | TLRY | |
|---|---|---|
Market Cap | $71.18B | $549.01M |
Volume | 14,872,321 | 3,292,073 |
Sector | Energy | Health |
52-Week High | $60.10 | $21.00 |
52-Week Low | $31.72 | $3.57 |
Typical Hold Time | 99 Days | 31 Days |
Enterprise Value | $79.91B | $716.15M |
Dividend Yield | 2.46% | — |
Signals from Pluang's Aura AI — not financial advice
SLB trades at $47.96, down 4.08% in the last session, with technical indicators showing bearish momentum. The company maintains strong fundamentals with consistent earnings beats and a robust $35.71B revenue base, though 2025 net income declined to $3.37B. Recent contract wins in Saudi Arabia, Oman, and Mozambique provide multi-year revenue visibility, supporting analyst optimism with an 84.85% buy rating and $64.58 consensus price target.
SLB presents a compelling value opportunity with significant upside to analyst targets, driven by expanding international contracts and solid cash flow generation. Key risks include oil price volatility and execution challenges in new projects. The stock's current technical weakness may offer an attractive entry point for long-term investors seeking energy sector exposure.
Tilray Brands (TLRY) trades at $3.715, down 1.72% on the day, as the stock continues to face significant pressure with bearish technical signals and fundamental challenges. The company reported a substantial net loss of $2.19 billion in 2025 despite $821 million in revenue, with negative cash flow from operations of $94.6 million. Recent earnings have consistently missed expectations, and technical indicators show a bearish trend with the stock trading near key support levels.
While TLRY shows attractive valuation metrics with P/S of 0.45 and P/B of 0.34, the company faces substantial execution risks amid persistent losses and negative cash flow. Analyst sentiment remains cautious with only 25% buy ratings, though the consensus price target of $65.01 suggests significant upside potential if the company can achieve profitability and growth targets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →